October 26, 2006

Nass – Senate Subcommittee on Bioterrorism & Public Health Preparedness – Biodefense

Submitted Testimony of Meryl Nass, MD Mount Desert Island Hospital Bar Harbor, Maine 04609 (207) 288-5082 ext.

Read More
Nass – Senate Subcommittee on Bioterrorism & Public Health Preparedness – Biodefense

October 26, 2006

FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk

FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk

Read More
FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk

October 26, 2006

Prescriptions for antidepressant declined 10%

Prescriptions for antidepressant declined 10% Thu, 13 May 2004 The controversy over the safety of antidepressant drugs

Read More
Prescriptions for antidepressant declined 10%

October 26, 2006

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street Sun,

Read More
FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street

October 26, 2006

UK issues ban on second SSRI antidepressant for children

UK issues ban on second SSRI antidepressant for children Sun, 21 Sep 2003 The UK Observer reports

Read More
UK issues ban on second SSRI antidepressant for children

October 26, 2006

Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials

Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials Sun, 19

Read More
Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials

October 26, 2006

An Open Letter to Officials of the National Institute of Mental Health

An Open Letter to Officials of the National Institute of Mental Health Fri, 30 Apr 2004 ALLIANCE

Read More
An Open Letter to Officials of the National Institute of Mental Health

October 26, 2006

Did Zoloft make him do it? FDA Zoloft data

Did Zoloft make him do it? FDA Zoloft data Tue, 8 Feb 2005 At issue beyond a

Read More
Did Zoloft make him do it? FDA Zoloft data

October 26, 2006

4 compelling reasons against Mental Health Parity

4 compelling reasons against Mental Health Parity Fri, 12 Sep 2003 Compelling reasons NOT to approve insurance

Read More
4 compelling reasons against Mental Health Parity

October 26, 2006

Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?

Are SSRIs and Atypical Antidepressants Safe / Effective for Children / Adolescents/ Neonates? Wed, 2 Mar 2005

Read More
Are SSRIs and Atypical Antidepressants Safe/ Effective for Children/ Adolescents/ Neonates?

October 26, 2006

Spitzer Expands drug Probe: Johnson & Johnson / New FDA analysis Confirms SSRI Risks to Kids – WSJ

Spitzer Expands drug Probe: Johnson & Johnson / New FDA analysis Confirms SSRI Risks to Kids –

Read More
Spitzer Expands drug Probe: Johnson & Johnson / New FDA analysis Confirms SSRI Risks to Kids – WSJ

October 26, 2006

FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune

FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune Thu, 24 Feb 2005 The

Read More
FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune

October 26, 2006

Asthma Drug trial Halted -Health Risk Are Suspected

Asthma Drug trial Halted -Health Risk Are Suspected Mon, 17 Mar 2003 A spate of recent articles

Read More
Asthma Drug trial Halted -Health Risk Are Suspected

October 26, 2006

Glaxo Pricing Under DOJ investigation / GAO Report Says Medicaid Overpays for Drugs

Glaxo Pricing Under DOJ investigation / GAO Report Says Medicaid Overpays for Drugs Wed, 9 Mar 2005

Read More
Glaxo Pricing Under DOJ investigation / GAO Report Says Medicaid Overpays for Drugs